Skip to main content

Diabetes

  • Study identifies Type 2 diabetes genetic variants linked to ethnicity

    PHILADELPHIA — A new study has found several gene variants associated with Type 2 diabetes across different ethnic groups.

  • Study: Blood from periodontal disease can be used to screen for diabetes

    NEW YORK — Oral blood samples drawn from periodontal inflammation can be used to measure HbA1C levels, a factor that indicates a patient's diabetes status, according to a New York University study.

  • Insulet, LifeScan ink deal

    BEDFORD, Mass. — Insulet and LifeScan have entered a partnership through which the latter's OneTouch blood-glucose monitoring technology will be integrated into the former's OmniPod Personal Diabetes Manager.

  • MyTelcare Diabetes Pal app now available

    BETHESDA, Md. — A provider of mobile health solutions has introduced a free application that synchronizes with a wireless blood-glucose meter.

    The MyTelcare Diabetes Pal, now available via the Apple App Store, allows patients and caregivers to use their iPhone, iPod Touch and/or iPad to visualize every glucose reading sent by the Telcare BGM (blood-glucose meter) while tracking medication, nutrition, activities and notes. What's more, the app also enables patients who don’t have the Telcare BGM to manually enter their blood-glucose data and track it over time.

  • Study: Genetic predisposition to dyslipidemia associated with Type 2 diabetes risk

    ATLANTA — People that are genetically predisposed to developing a condition that causes high blood cholesterol levels may be at an increased risk of developing Type 2 diabetes, according to a new study.

  • Bydureon officially hits market

    SAN DIEGO — Amylin Pharmaceuticals and Alkermes announced that their Type 2 diabetes treatment now is available by prescription in U.S. pharmacies.

    Bydureon (exenatide extended-release for injectable suspension) received approval from the Food and Drug Administration on Jan. 27 as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes.

  • Diabetes Prevention and Control Alliance extended to Safeway stores in select markets

    MINNETONKA, Minn. — Another retailer has joined the UnitedHealth Group's Diabetes Prevention and Control Alliance, an initiative designed to help address the growing epidemic of prediabetes and Type 2 diabetes.

  • CVS' Project Health to deliver more than $21M worth of preventive health screenings

    WOONSOCKET, R.I. — CVS/pharmacy announced on Wednesday the launch of Project Health (Proyecto Salud in Spanish), a wellness program delivering more than $21 million worth of free health screenings to multicultural communities.

X
This ad will auto-close in 10 seconds